Alferon N injection

Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders. Its flagship products include Alferon N Injection, Ampligen and Alferon LDO. Benzinga recently had the chance to speak with the...

Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders. Its flagship products include Alferon N Injection, Ampligen and Alferon LDO. Benzinga recently had the chance to speak with the...